ContraFect Corp Share Price Nasdaq
Equities
US2123262014
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
03/05 | North American Morning Briefing : Apple, Amgen -2- | DJ |
26/04 | North American Morning Briefing : Tech Still in -2- | DJ |
Sales 2021 | - | Sales 2022 | - | Capitalization | 4.19M 350M |
---|---|---|---|---|---|
Net income 2021 | -20M -1.67B | Net income 2022 | -65M -5.42B | EV / Sales 2021 | - |
Net cash position 2021 | 51.02M 4.26B | Net cash position 2022 | 10.8M 901M | EV / Sales 2022 | - |
P/E ratio 2021 |
-4.77
x | P/E ratio 2022 |
-0.06
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 99.98% |
1st Jan change | Capi. | |
---|---|---|
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |